mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.03 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.03 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.03 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.04 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.04 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.58 |
0.05 |